Attention-deficit hyperactivity disorder (ADHD) is the most common type of behavioral disorder, affecting up to 10% of children and adolescents aged 18 and younger.

Although prevalence usually declines with age, up to 65% of hyperactive children are still symptomatic as adults.

Over the past decade, researchers have studied the connection between childhood ADHD and deficiencies in essential fats and phospholipids.

But can supplementing with phosphatidylserine aid in improving symptoms?

Dr. Mike shares with you the latest research on treating ADHD with this chemical.